874285-16-2 Usage
Amine derivative
It is an amine derivative This means that the compound is derived from an amine (a nitrogen-hydrogen compound) by replacing one or more hydrogen atoms with other functional groups.
Phenyl ring
The compound has a phenyl ring This refers to a six-carbon ring structure with alternating single and double bonds, which is a fundamental structure in organic chemistry.
Substitution with bromine and fluorine atoms
The phenyl ring is substituted with a bromine atom and a fluorine atom This means that hydrogen atoms on the phenyl ring are replaced by bromine and fluorine atoms, giving the compound its unique properties.
Synthesis of pharmaceuticals
It is used in the synthesis of various pharmaceuticals This indicates that 2-(2-bromo-4-fluorophenyl)ethanamine serves as a building block or intermediate in the production of medications.
Reagent in organic chemistry reactions
It can be employed as a reagent in organic chemistry reactions This means that the compound is used to facilitate or participate in chemical reactions, often to synthesize new compounds or modify existing ones.
Hazardous if not used properly
It is important to handle this chemical with care This highlights the potential risks associated with the compound, such as toxicity, reactivity, or other hazardous properties.
Storage conditions
Store in a cool, dry place away from light and heat sources This ensures the stability and reactivity of the compound, preventing decomposition or unwanted reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 874285-16-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,4,2,8 and 5 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 874285-16:
(8*8)+(7*7)+(6*4)+(5*2)+(4*8)+(3*5)+(2*1)+(1*6)=202
202 % 10 = 2
So 874285-16-2 is a valid CAS Registry Number.
874285-16-2Relevant articles and documents
TRIAZOLYL AMINOPYRIMIDINE COMPOUNDS
-
Page/Page column 11, (2009/01/20)
The present invention provides triazolyl aminopyrimidine compounds useful in the treatment of cancer.